Testing oligonucleotide deprotection conditions on Acrylamide-dT
For standard deprotection conditions: Acrylamide-dT (10mg) was added to a 1ml solution of aqueous ammonia (30%). The resulting suspension was sealed, shaken, and heated to 60°C for 6 hours. The solvent was then evaporated, and the crude dissolved in deuterated DMSO and analysed by 1 H, 13 C, and 2D NMR. The solid crude was also analysed by mass spectrometry.
For ultramild deprotection conditions: Acrylamide-dT (10mg) was added to a 1ml freshly prepared solution of potassium carbonate in methanol (0.05M). The resulting suspension was sealed, shaken, and left standing at room temperature for 12 hours. The solvent was then evaporated, and the crude dissolved in deuterated DMSO, and analysed by 1 H NMR. Figure S11-HMBC NMR spectrum of Acrylamide-dT in deuterated DMSO after heating with aqueous ammonia (highlighted sections denote significant changes to the spectra).
Scheme S1-Reaction of Acrylamide-dT with hot aqueous ammonia
The changes to the NMR spectra (Figures S8 -S11) are consisent with NH 3 reacting with the acrylamide group of Acrylamide-dT as shown above. In contrast, the treatment of Acrylamide-dT with methanolic potassium carbonate resulted in no changes to the spectrum, as shown below in Figure S12 . 
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Purification and characterisation of unmodified and Acrylamide-dT modified TBA
Semi preparative HPLC purification was performed on an Agilent Technologies 1260 Infinity system using a Phenomenex Clarity 5 μm Oligo-RP LC 250 x 10 mm column. 1 ml of sample was injected with a run time of 45 minutes for each sample, at a flow rate of 3 ml/min. The column was heated to 60 °C prior to sample injection. The UV/vis absorbance of each run was monitored at 260 nm. The solvent gradients used are listed in the table below. Collected fractions were evaporated to dryness, diluted to 1 ml in Milli-Q water, and desalted using a NAP-10 column (GE Healthcare), whilst eluting to 1.5 ml.
Purity of oligonucleotides was determined by analytical HPLC using a Phenomenex Clarity 5 μm Oligo RP LC 250 x 4.6 mm column on either a Shimadzu HPLC or an Agilent Technologies 1260 Infinity system. The column was heated to 60 °C prior to sample injection. 20 μl of sample was injected with a run time of 45 minutes for each sample, at a flow rate of 1 ml/min. Solvent gradients used were identical to semi preparative HPLC. The UV/vis absorbance of each run was monitored at 260 nm. Samples showing >95% purity by analytical HPLC were deemed sufficiently pure for use in experiments.
Samples showing <95% purity were repurified by semi preparative HPLC. 
Gel electromobility shift assays of unmodified and Acrylamide-dT modified TBA with thrombin
Experiments were performed on 12% native polyacrylamide gels with 1 x TBE buffer and 10mM potassium chloride, using 1x TBE buffer with 10mM potassium chloride as a running buffer. Gels were run on Bio-rad Mini-PROTEAN® gel kits with a Bio-rad PowerPac (highest voltage: 5000V/500mA/400W). After electrophoresis, gels were stained with Diamond™ nucleic acid dye and visualised under UV with an AlphaImager HP gel imager from Alpha Innotech.
Gel electromobility shift assays: 50μl aqueous solutions of DNA (1 μM) and thrombin (1 μM) in KCl (10 mM), tris.HCl buffer (10 mM, pH 7.5), and glycerol (3%) were prepared. 10μl of each sample was loaded into wells and gels were run at 100V for 1 hour. 
